Health / Drugs & FDA
FDA grants accelerated approval for head and neck cancer treatment
The approval covers certain adults whose recurrent or metastatic disease progressed after chemotherapy and immunotherapy.
Coverage
Health
Health / Drugs & FDA
FDA finalizes potency guidance for cell and gene therapies
The guidance replaces a 2011 document and asks makers to build potency checks into every development stage.